Cell and Gene Therapy Drug Delivery Devices Market Growth Driven by Rising Cancer Incidence and Advanced Biopharmaceutical Innovations

InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Cell and Gene Therapy Drug Delivery Devices Market- by Products (Subretinal Injection Cannula, Extension Tube, Intravenous Catheter, Sterile Insulin Syringe, Pre-Filled Syringe, and Infusion Bags), Commercialized Drugs (Luxturna, Kymriah, Provenge, Zolgensma, Yescarta, and Strimvelis), Trends, Industry Competition Analysis, Revenue and Forecast To 2035."

Global Cell and Gene Therapy Drug Delivery Devices Market Size is valued at USD 1.16 Bn in 2025 and is predicted ato reach USD 3.07 Bn by the year 2035 at a 10.6% CAGR during the forecast period for 2026 to 2035.

Get Free Access to Demo Report, Excel Pivot and ToC: https://www.insightaceanalytic.com/request-sample/1025

In the field of cell and gene therapy, donor-derived cells, proteins, or genetic material (DNA) are extracted, modified, and reintroduced to create highly personalized therapeutic interventions. Unlike conventional pharmaceuticals, these therapies offer the potential for long-lasting clinical effects. CAR-T cell therapies, which integrate both cellular and gene-based approaches, represent a key segment within the cell and gene therapy landscape. The drug delivery sector for these therapies is undergoing a transformative phase, with its full potential only beginning to emerge. These treatments demonstrate significant promise in achieving durable responses, while increasingly improving the ability to selectively target diseased cells without affecting healthy tissues.

The market's expansion is primarily driven by factors such as the rising prevalence of cancer and chronic diseases, increased funding for cell and gene therapy development, growing demand for innovative treatments for rare disorders, escalating biopharmaceutical R&D expenditures, and a growing number of FDA-approved therapies and ongoing clinical trials.

The demand for specialized drug delivery devices is expected to rise in line with the aging global population, increasing cancer incidence, and the prevalence of genetic disorders. Moreover, substantial investments by industry stakeholders in the development of cell and gene therapies, as well as associated delivery technologies, are supporting market growth. The number of hereditary and chronic disease indications under clinical investigation has expanded in recent years, further driving the adoption of advanced delivery systems.

Given the robust pipeline of therapies, ongoing regulatory approvals, and emerging technological innovations, the market for cell and gene therapy drug delivery devices is projected to experience substantial growth over the coming years. Nevertheless, factors such as high manufacturing costs and operational disruptions during global health crises have posed challenges, potentially constraining market expansion in the short term.

Expert Knowledge, Just a Click Away: https://calendly.com/insightaceanalytic/30min?month=2025-02

North America is anticipated to be the major contributor to the Cell and Gene Therapy Drug Delivery Devices market over the forecast years. It is due to the growing number of partnerships between several small and medium-sized businesses and conglomerates that have allowed for the development of high-quality, reasonably priced pharmaceuticals. Another significant factor that significantly contributed to the expansion of the regional market was the rising occurrences of neurodegenerative illnesses and the rising demand for effective treatments for gene disorders to be found through research, diagnostics, and synthetic biology.

In addition, the Asia Pacific Cell and Gene Therapy Drug Delivery Devices market is expected to register significant growth during the estimated period due to significant investments made by pharmaceutical and biotechnology businesses, enhanced healthcare infrastructure, increased per capita income, early availability of authorised medications, and presence of cutting-edge research institutions and laboratories in the area.

Major market players operating in the Cell and Gene Therapy Drug Delivery Devices market include
Amgen Inc., Becton, Bausch & Lomb Incorporated., Castle Creek Biosciences, Inc. (Fibrocell Science, Inc.), Vericel Corporation, Bluebird bio, Inc., Dendreon Pharmaceuticals LLC., Dickinson and Company, Helixmith Co., Ltd (ViroMed Co., Ltd), Kite Pharma, Inc., Human Stem Cells Institute, Novartis AG, Orchard Therapeutics plc., Pfizer, Inc., Renova Therapeutics, Kolon TissueGene, Inc., Spark Therapeutics, Inc., uniQure N.V., and list of other prominent players.

Recent collaborations and agreements in the market:
• In 2020, Lonza (Switzerland) and IsoPlexis (US) teamed up to create the next generation of precision cell therapy manufacturing.
• In 2020, Danaher acquired General Electric Company's Life Sciences division's Biopharma business (US). Danaher acquired General Electric Company's Life Sciences division's Biopharma business. Cytiva, a standalone operational company within Danaher's Life Sciences segment, was formed as a result of the acquisition.
• In 2019, Thermo Fisher Scientific spent USD 24 million in its Inchinnan (Scotland) location to increase its worldwide bioproduction capabilities by adding large-volume liquid manufacturing capacity for cell culture medium.

Unlock Your GTM Strategy: https://www.insightaceanalytic.com/customisation/1025

Market Segments
Global Cell and Gene Therapy Drug Delivery Devices Market, by Products, 2022-2030 (Value US$ Th)
• Subretinal Injection Cannula
• Extension Tube
• Intravenous Catheter
• Sterile Insulin Syringe
• Pre-Filled Syringe
• Infusion Bags
Global Cell and Gene Therapy Drug Delivery Devices Market, by Commercialized Drugs, 2022-2030 (Value US$ Th)
• Luxturna
• Kymriah
• Provenge
• Zolgensma
• Yescarta
• Strimvelis
Global Cell and Gene Therapy Drug Delivery Devices Market, by Region, 2022-2030 (Value US$ Th)
• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa
North America Cell and Gene Therapy Drug Delivery Devices Market, by Country, 2022-2030 (Value US$ Th)
• U.S.
• Canada
Europe Cell and Gene Therapy Drug Delivery Devices Market, by Country, 2022-2030 (Value US$ Th)
• Germany
• France
• Italy
• Spain
• Russia
• Rest of Europe
Asia Pacific Cell and Gene Therapy Drug Delivery Devices Market, by Country, 2022-2030 (Value US$ Th)
• India
• China
• Japan
• South Korea
• Australia & New Zealand
Latin America Cell and Gene Therapy Drug Delivery Devices Market, by Country, 2022-2030 (Value US$ Th)
• Brazil
• Mexico
• Rest of Latin America
Middle East & Africa Cell and Gene Therapy Drug Delivery Devices Market, by Country, 2022-2030 (Value US$ Th)
• GCC Countries
• South Africa
• Rest of Middle East & Africa

Why should buy this report:
 To receive a comprehensive analysis of the prospects for the global Cell and Gene Therapy Drug Delivery Devices market
 To receive an industry overview and future trends of the Cell and Gene Therapy Drug Delivery Devices market
 To analyze the Cell and Gene Therapy Drug Delivery Devices market drivers and challenges
 To get information on the Cell and Gene Therapy Drug Delivery Devices market value (US$Th) forecast to 2030
 Significant investments, mergers & acquisitions in the Cell and Gene Therapy Drug Delivery Devices market industry

Read Overview Report- https://www.insightaceanalytic.com/report/global-cell-and-gene-therapy-drug-delivery-devices-market-/1025

About Us:
InsightAce Analytic is a market research and consulting firm that enables clients to make strategic decisions. Our qualitative and quantitative market intelligence solutions inform the need for market and competitive intelligence to expand businesses. We help clients gain competitive advantage by identifying untapped markets, exploring new and competing technologies, segmenting potential markets and repositioning products. Our expertise is in providing syndicated and custom market intelligence reports with an in-depth analysis with key market insights in a timely and cost-effective manner.

Contact us:
InsightAce Analytic Pvt. Ltd.
Visit: https://www.insightaceanalytic.com/
Tel : +1 607 400-7072
Asia: +91 79 72967118
info@insightaceanalytic.com

This release was published on openPR.